Beer is a brutal enterprise, and Dolf van den Brink realized the laborious manner. Heineken introduced that its CEO will step down Could 31 after practically six years main the world’s second-largest beer maker. Van den Brink “arrived with excessive expectations, however Heineken has not delivered on them,” RBC Capital Markets analyst James Edwardes Jones instructed Reuters.
Van den Brink took the job in June 2020 in the course of the Covid-19 pandemic and presided over a turbulent interval marked by large value inflation, falling gross sales, declining margins and a battered share worth.
Van den Brink is the most recent CEO casualty. Brewers have struggled to promote extra beer, with hopes of a gross sales revival repeatedly knocked astray by dangerous climate, political uncertainty and shifting attitudes towards consuming amongst youthful folks. The rise of weight-loss medication like Ozempic may additional dampen food and drinks gross sales. Heineken’s board will now seek for a successor.
Beer is a brutal enterprise, and Dolf van den Brink realized the laborious manner. Heineken introduced that its CEO will step down Could 31 after practically six years main the world’s second-largest beer maker. Van den Brink “arrived with excessive expectations, however Heineken has not delivered on them,” RBC Capital Markets analyst James Edwardes Jones instructed Reuters.
Van den Brink took the job in June 2020 in the course of the Covid-19 pandemic and presided over a turbulent interval marked by large value inflation, falling gross sales, declining margins and a battered share worth.
Van den Brink is the most recent CEO casualty. Brewers have struggled to promote extra beer, with hopes of a gross sales revival repeatedly knocked astray by dangerous climate, political uncertainty and shifting attitudes towards consuming amongst youthful folks. The rise of weight-loss medication like Ozempic may additional dampen food and drinks gross sales. Heineken’s board will now seek for a successor.
